Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hertl

Showing results (91-100 of 237) with videos related to

Pageof 24
Sort By:
The Journal of Investigative Dermatology|June 20, 2008
Rituximab exerts a dual effect in pemphigus vulgarisRüdiger Eming, Angela Nagel, Sonja Wolff-Franke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2006
Autoreactive T and B cells from bullous pemphigoid (BP) patients recognize epitopes clustered in distinct regions of BP180 and BP230Sybille Thoma-Uszynski, Wolfgang Uter, Susanne Schwietzke, et al.
European Journal of Dermatology : EJD|July 16, 2020
Amyopathic and anti-TIF1 gamma-positive dermatomyositis: analysis of a monocentric cohort and proposal to update diagnostic criteriaDario Didona, Hazem A Juratli, Luca Scarsella, et al.
Frontiers in Medicine|April 17, 2026
A case series of immune checkpoint inhibitor-induced bullous pemphigoid successfully treated with dupilumab and evidence for the BP180 midportion epitope as a preferential autoantigenic targetDario Didona, Feliciana Mariotti, Anna Pira, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 21, 2022
Dyshidrosiform pemphigoid induced by ustekinumab in a patient with ulcerative colitisDario Didona, Tomas Cunha, Julia Hinterseher, et al.
The Journal of Investigative Dermatology|March 14, 2009
Rituximab mediates a strong elevation of B-cell-activating factor associated with increased pathogen-specific IgG but not autoantibodies in pemphigus vulgarisAngela Nagel, Eva Podstawa, Markus Eickmann, et al.
Clinics in Dermatology|December 6, 2011
Severity score indexes for blistering diseasesBenjamin S Daniel, Michael Hertl, Victoria P Werth, et al.
Proteomics|August 29, 2017
Proteome Dynamics in Biobanked Horse Peripheral Blood Derived Lymphocytes (PBL) with Induced Autoimmune UveitisStefanie M Hauck, Marlen F Lepper, Michael Hertl, et al.
Experimental Dermatology|January 18, 2014
Autoreactive T cells in the immune pathogenesis of pemphigus vulgarisKyle T Amber, Patrick Staropoli, Michael I Shiman, et al.
Frontiers in Immunology|July 2, 2019
Identification of Autoreactive B Cell Subpopulations in Peripheral Blood of Autoimmune Patients With Pemphigus VulgarisRobert Pollmann, Elias Walter, Thomas Schmidt, et al.
Pageof 24

Showing results (91-100 of 237) with videos related to

Sort By:
Pageof 24
The Journal of Investigative Dermatology|June 20, 2008
Rituximab exerts a dual effect in pemphigus vulgarisRüdiger Eming, Angela Nagel, Sonja Wolff-Franke, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2006
Autoreactive T and B cells from bullous pemphigoid (BP) patients recognize epitopes clustered in distinct regions of BP180 and BP230Sybille Thoma-Uszynski, Wolfgang Uter, Susanne Schwietzke, et al.
European Journal of Dermatology : EJD|July 16, 2020
Amyopathic and anti-TIF1 gamma-positive dermatomyositis: analysis of a monocentric cohort and proposal to update diagnostic criteriaDario Didona, Hazem A Juratli, Luca Scarsella, et al.
Frontiers in Medicine|April 17, 2026
A case series of immune checkpoint inhibitor-induced bullous pemphigoid successfully treated with dupilumab and evidence for the BP180 midportion epitope as a preferential autoantigenic targetDario Didona, Feliciana Mariotti, Anna Pira, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 21, 2022
Dyshidrosiform pemphigoid induced by ustekinumab in a patient with ulcerative colitisDario Didona, Tomas Cunha, Julia Hinterseher, et al.
The Journal of Investigative Dermatology|March 14, 2009
Rituximab mediates a strong elevation of B-cell-activating factor associated with increased pathogen-specific IgG but not autoantibodies in pemphigus vulgarisAngela Nagel, Eva Podstawa, Markus Eickmann, et al.
Clinics in Dermatology|December 6, 2011
Severity score indexes for blistering diseasesBenjamin S Daniel, Michael Hertl, Victoria P Werth, et al.
Proteomics|August 29, 2017
Proteome Dynamics in Biobanked Horse Peripheral Blood Derived Lymphocytes (PBL) with Induced Autoimmune UveitisStefanie M Hauck, Marlen F Lepper, Michael Hertl, et al.
Experimental Dermatology|January 18, 2014
Autoreactive T cells in the immune pathogenesis of pemphigus vulgarisKyle T Amber, Patrick Staropoli, Michael I Shiman, et al.
Frontiers in Immunology|July 2, 2019
Identification of Autoreactive B Cell Subpopulations in Peripheral Blood of Autoimmune Patients With Pemphigus VulgarisRobert Pollmann, Elias Walter, Thomas Schmidt, et al.
Pageof 24